Back to News
Market Impact: 0.2
Phathom Says BDR Pharmaceuticals Sues FDA Over VOQUEZNA Exclusivity
Source: Nasdaq
Legal & LitigationRegulation & LegislationHealthcare & Biotech
Phathom Pharmaceuticals said BDR Pharmaceuticals International, based in Mumbai, filed a lawsuit against the U.S. FDA challenging an agency decision. The article excerpt does not specify what the FDA granted or provide further details on the claims or potential effects.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Looters hit 3,000 French businesses. Within hours, the haul was trending on Vinted under the riot’s date
- Exclusive-Boeing supplier dispute has halted 777 freighter production for two months, sources say
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Oncologists Cheer Melanoma Data
- Meta shares are down 9% this week. Here's why Mike Khouw is buying now